Surface Disinfectant Market by Composition (Alcohols, Chlorine, Quaternary Ammonium, H2O2), Type (Liquid, Wipes, Sprays), Application (Surface Disinfection), End User (Hospitals, Clinics, Diagnostic Laboratories), & Region - Global Forecast to 2030
세계 표면 소독제 시장 규모는 2025년 30억 4,000만 달러에서 2030년까지 43억 8,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 7.6%의 CAGR로 성장할 것으로 예상됩니다.
| 조사 범위 |
| 조사 대상 연도 |
2024-2030년 |
| 기준 연도 |
2024년 |
| 예측 기간 |
2024-2030년 |
| 단위 |
10억 달러 |
| 부문 |
조성, 유형, 용도, 최종사용자, 지역 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 중동 및 아프리카, 라틴아메리카 |
이러한 배경에는 살균을 위한 첨단 표면 소독제 사용 증가, 외과 수술의 증가, 병원내 감염을 줄이기 위한 감염 대책에 대한 관심 증가, 의료 환경의 위생에 대한 소비자의 인식 증가 등이 있습니다. 그러나 화학 소독제 사용으로 인한 잠재적 영향과 대체 표면 소독 방법의 채택 증가는 시장의 주요 억제요인으로 작용하고 있습니다. 또한, 엄격한 규제 환경은 시장 성장에 큰 걸림돌로 작용하고 있습니다.
표면 소독 부문은 2024년 가장 큰 시장 점유율을 차지했습니다.
용도별로 표면 소독제 시장은 표면 소독, 기구 소독, 기타 용도로 구분됩니다. 표면 소독 부문이 2024년 가장 큰 시장 점유율을 차지했습니다. 이 부문이 높은 점유율을 차지한 이유는 전 세계적으로 병원내 감염이 많이 발생하고 있으며, 이러한 표면을 청소하기 위해 많은 양의 소독제가 필요하기 때문입니다. 병동, 수술실, 리셉션, 진료소 등의 공간에는 다양한 세균과 박테리아가 서식하기 때문에 욕실, 벽, 가구의 소독이 필요합니다. 이러한 영역은 표면적이 넓기 때문에 청소에 많은 양의 소독제가 필요합니다.
2022년, WHO는 고소득 국가의 급성기 환자 100명당 고소득 국가의 환자 7명, 중저소득 국가의 환자 15명이 입원 중 최소 한 번 이상 HAI가 발생한다고 보고했습니다. 오염된 표면이 병원균의 확산에 크게 기여한다는 점을 고려할 때, HAI의 증가는 감염의 전파를 예방하고 환자의 안전을 도모하기 위해 의료 분야에서 효과적인 표면 소독 기술에 대한 요구가 높아지고 있음을 보여줍니다.
병원, 클리닉 및 ASC 부문은 2024년 표면 소독제 시장에서 가장 큰 시장 점유율을 차지했습니다.
최종사용자별로 표면 소독제 시장은 병원, 클리닉 및 ASC, 진단 연구소, 제약 및 생명공학 기업, 연구소로 분류되며, 2024년에는 병원, 클리닉 및 ASC가 표면 소독제 시장에서 가장 큰 시장 점유율을 차지했습니다. 이 부문의 높은 점유율은 병원 및 ASC의 높은 HAI 유병률, 소독에 대한 엄격한 규제, 의료비 증가에 기인하는 것으로 추정됩니다.
NIH 2023 논문에 따르면 HAI는 미국에서는 전체 입원 환자의 3.2%, 유럽연합/유럽 경제권에서는 6.5%에 영향을 미치며, 중저소득 국가에서는 유병률이 5.7%-19.2%에 달합니다. 미국 질병예방통제센터(CDC, 2022)의 추산에 따르면, 미국 병원에서는 매년 HAI가 170만 건의 감염과 9만 건의 관련 사망을 유발하고 있으며, HAI의 높은 이환율과 이에 따른 모든 이해관계자의 비용 부담은 소독 및 멸균 서비스와 같은 감염 방지 대책을 의료기기에 도입하도록 장려하고 있습니다.
지역별로는 유럽이 2024년 표면 소독제 시장 점유율 2위를 차지했습니다.
세계 표면 소독제 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카의 5개 주요 지역으로 분류되며, 2024년 유럽 표면 소독제 시장은 두 번째로 큰 지역 시장으로, HAI 유병률 증가, 노령 인구 증가, 살균 및 소독에 대한 정부의 노력 증가, 이 지역의 여러 소독 및 살균 시장 기업의 존재감 증가가 유럽 표면 소독제 시장의 주요 촉진요인입니다. 유럽 표면 소독제 시장에서 가장 큰 점유율을 차지하는 국가는 독일입니다.
세계의 표면 소독제 시장에 대해 조사 분석했으며, 주요 촉진요인과 억제요인, 경쟁 상황, 향후 동향 등의 정보를 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 주요 조사 결과
- 표면 소독제 시장 개요
- 아시아태평양의 표면 소독제 시장 : 유형별, 국가별
- 표면 소독제 시장 : 국가별
- 표면 소독제 시장 : 지역별(2025년·2030년)
- 표면 소독제 시장 : 신흥 경제국 시장 vs. 선진 시장
제5장 시장 개요
- 소개
- 시장 역학
- 고객 비즈니스에 영향을 미치는 동향/혼란
- 가격 분석
- 평균판매가격 동향 : 주요 기업별
- 평균판매가격 동향 : 지역별
- 밸류체인 분석
- 공급망 분석
- 생태계 분석
- 투자와 자금 조달 시나리오
- 기술 분석
- 특허 분석
- 무역 분석
- HS 코드 380894 수입 데이터
- HS 코드 380894 수출 데이터
- 주요 회의와 이벤트(2025-2026년)
- 규제 상황
- 규제기관, 정부기관, 기타 조직
- 규제 관할권
- 규제 분석
- Porter's Five Forces 분석
- 주요 이해관계자와 구입 기준
- 표면 소독제 시장에 대한 AI/생성형 AI의 영향
- 소개
- 표면 소독제 시장의 AI 시장 가능성
- AI 이용 사례
- 표면 소독제 생태계에서 생성형 AI의 미래
제6장 표면 소독제 시장 : 조성별
- 소개
- 알코올
- 염소 화합물
- 4급 암모늄 화합물
- 과산화수소
- 과초산
- 페놀 화합물
- 기타 조성
제7장 표면 소독제 시장 : 유형별
제8장 표면 소독제 시장 : 용도별
제9장 표면 소독제 시장 : 최종사용자별
- 소개
- 병원·진료소·ASCS
- 진단 연구소
- 제약·바이오테크놀러지 기업
- 연구소
제10장 표면 소독제 시장 : 지역별
- 소개
- 북미
- 유럽
- 유럽의 거시경제 전망
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 라틴아메리카의 거시경제 전망
- 브라질
- 멕시코
- 기타 라틴아메리카
- 중동 및 아프리카
제11장 경쟁 구도
- 소개
- 주요 진출 기업 전략/강점
- 매출 분석(2019-2023년)
- 시장 점유율 분석(2024년)
- 기업 평가와 재무 지표
- 브랜드/제품의 비교
- 기업 평가 매트릭스 : 주요 기업(2024년)
- 기업 평가 매트릭스 : 스타트업/중소기업(2024년)
- 경쟁 시나리오
제12장 기업 개요
- 주요 기업
- RECKITT BENCKISER
- PROCTER & GAMBLE
- 3M
- THE CLOROX COMPANY
- ECOLAB
- STERIS
- PAUL HARTMANN AG
- SC JOHNSON PROFESSIONAL USA, INC.
- CARROLLCLEAN
- MEDALKAN
- GOJO INDUSTRIES, INC.
- WHITELEY
- SANOSIL AG
- BETCO
- METREX RESEARCH, LLC
- 기타 기업
- ACURO ORGANICS LIMITED
- PHARMAX LIMITED
- PDI, INC.
- RUHOF
- CARENOW
- CETYLITE, INC.
- MICRO-SCIENTIFIC, LLC
- PAL INTERNATIONAL
- BRULIN
- KCWW
- AMITY INTERNATIONAL
- WEXFORD LABS, INC.
- DETROX
제13장 부록
ksm
The global surface disinfectant market is projected to reach USD 4.38 billion by 2030 from USD 3.04 billion in 2025, at a CAGR of 7.6% during the forecast period.
| Scope of the Report |
|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD billion) |
| Segments | Composition, Type, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Middle East & Africa, and Latin America |
This is due to the rising adoption of advanced surface disinfectants for sanitization, increasing surgical procedures, growing focus on infection control measures to mitigate hospital-acquired infections, and increasing consumer awareness of hygiene in healthcare settings. However, the potential consequences of chemical disinfectant use and the increasing adoption of alternative surface disinfection methods are the major restraints to the market. Additionally, the strict regulatory requirement landscape is a major challenge for market growth.
The surface disinfection segment accounted for the largest market share in 2024.
Based on application, the surface disinfectant market is segmented into surface disinfection, instrument disinfection, and other applications. The surface disinfection segment accounted for the larges market share in 2024. The large share of this application segment can be attributed to the high prevalence of hospital-acquired infections across the globe and the higher volume of disinfectants required to clean these surfaces. Areas such as hospital wards, operation theaters, reception areas, and clinics are home to a wide range of germs and bacteria, necessitating disinfecting bathrooms, walls, and furniture. These areas possess large surface areas and, therefore, need a highly large quantity of disinfectants for their cleaning.
In 2022, the WHO reported that for every 100 acute care patients in high-income countries, seven high-income-country patients and 15 low- and middle-income-country patients will develop at least one HAI while in hospital. Considering the key contribution of contaminated surfaces to pathogen spread, increasing HAIs represent a growing call for effective surface disinfection techniques within healthcare to prevent infection transmission and promote patient safety.
The hospitals, clinics, and ASCs segment accounted for the largest market share in 2024 in the surface disinfectant market.
Based on end user, the surface disinfectant market is segmented into hospitals, clinics, and ASCs, diagnostic laboratories, pharmaceutical & biotechnology companies, and research laboratories. In 2024, the hospitals, clinics, and ASCs accounted for the largest market share in the surface disinfectant market. The large share of this segment can be attributed to the high prevalence of HAIs in hospitals and ASCs, stringent regulations for disinfection, and rising healthcare expenditure.
According to an article in NIH 2023, HAIs affect 3.2% of all hospitalized patients in the US and 6.5% in the European Union/European Economic Area, while in low- and middle-income countries, the prevalence rate ranges between 5.7% and 19.2%. The Centers for Disease Control and Prevention (CDC, 2022) estimated that in American hospitals, HAIs account for an estimated 1.7 million infections and 90,000 associated deaths each year. The high incidence of HAIs and the resulting cost burden on all the stakeholders have driven the adoption of infection prevention measures, such as disinfection and sterilization services, for their use in medical devices.
Europe accounted for the second-largest share of the surface disinfectant market by region in 2024.
The global surface disinfectant market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The surface disinfectant market in Europe in 2024 is the second-largest regional market. The rising prevalence of HAIs, the growing geriatric population, the increasing number of government initiatives for sterilization and disinfection, and the increasing presence of several disinfection and sterilization market players in the region are the major factors driving the surface disinfectant market in Europe. Germany accounted for the largest share of the surface disinfectant market in Europe.
The rapidly growing aging population, the increasing demand for healthcare services, the rising number of advancements in medical sciences, and rising life expectancies are also expected to result in an increasing number of surgical procedures performed yearly. According to the UN Population Division, Germany's population aged 65 and above is expected to rise by 41% to around 24 million by 2050, accounting for around 30% of the total population. This, in turn, will increase the number of spinal, orthopedic, and cardiovascular procedures performed, thereby driving the growth of HAIs and increasing the demand for surface disinfectants in Germany.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30%
- By Designation: C Level- 27%, Director Level- 18% and Others- 55%
- By Region: North America- 35%, Europe- 30%, Asia Pacific- 22%, Latin America- 10%, and Middle East & Africa- 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the surface disinfectant market are Reckitt Benckiser (UK), Procter & Gamble (US), 3M (US), Ecolab (US), The Clorox Company (US), STERIS (US), SC Johnson Professional USA, Inc. (US), CarrollCLEAN (US), Paul Hartmann AG (Germany), Medalkan (Greece), GOJO Industries, Inc. (US), Whiteley (Australia), Sanosil AG (Switzerland), Betco (US), Metrex Research, LLC. (US), KCWW (US), Acuro Organics Limited (India), Pharmax Limited (Canada), PDI, Inc. (US), CARENOW (India), Cetylite, Inc. (US), Micro-Scientific, LLC (US), Pal International (UK), Brulin (US), Amity International (UK), Wexford Labs, Inc. (US), Detrox (Turkiye), and Ruhof (US).
Research Coverage
This report studies the surface disinfectant market based on composition, type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of Key drivers (Growing focus on mitigating hospital-acquired infections, rising adoption of advanced surface disinfectants for sanitization, growing consumer awareness of hygiene in healthcare settings, and increasing surgical procedures), restraints (Potential consequences of chemical disinfectant use, increasing adoption of alternative surface disinfection methods), challenge (Strict regulatory requirements), opportunity (Rising healthcare expenditures in emerging economies, shift toward eco-friendly & non-toxic disinfectants, increasing presence of medical device and pharmaceutical companies in developing countries)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the surface disinfectant market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the surface disinfectant market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the surface disinfectant market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 UNIT CONSIDERED
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key sources for secondary data
- 2.1.1.2 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key primary sources
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Key industry insights
- 2.1.2.4 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Company revenue estimation approach
- 2.2.1.1.1 Presentations of companies and primary interviews
- 2.2.1.1.2 Primary interviews
- 2.2.2 TOP-DOWN APPROACH
- 2.3 DATA TRIANGULATION
- 2.4 MARKET SHARE ANALYSIS
- 2.5 RESEARCH ASSUMPTIONS
- 2.5.1 PARAMETRIC ASSUMPTIONS
- 2.5.2 GROWTH RATE ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.6.2 SCOPE-RELATED LIMITATIONS
- 2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 SURFACE DISINFECTANT MARKET OVERVIEW
- 4.2 ASIA PACIFIC SURFACE DISINFECTANT MARKET, BY TYPE AND COUNTRY
- 4.3 SURFACE DISINFECTANT MARKET, BY COUNTRY
- 4.4 SURFACE DISINFECTANT MARKET, REGIONAL MIX, 2025 VS. 2030
- 4.5 SURFACE DISINFECTANT MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Growing focus on mitigating hospital-acquired infections
- 5.2.1.2 Rising adoption of advanced surface disinfectants for sanitization
- 5.2.1.3 Growing consumer awareness of hygiene in healthcare settings
- 5.2.1.4 Increasing surgical procedures worldwide
- 5.2.2 RESTRAINTS
- 5.2.2.1 Potential consequences of chemical disinfectant use
- 5.2.2.2 Increasing adoption of alternative surface disinfection methods
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising healthcare expenditure in emerging economies
- 5.2.3.2 Shift toward eco-friendly and non-toxic disinfectants
- 5.2.3.3 Increasing presence of medical device and pharmaceutical companies in developing countries
- 5.2.4 CHALLENGES
- 5.2.4.1 Strict regulatory requirements
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
- 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 SUPPLY CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 INVESTMENT AND FUNDING SCENARIO
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
- 5.9.1.1 Surface disinfection
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.10 PATENT ANALYSIS
- 5.11 TRADE ANALYSIS
- 5.11.1 IMPORT DATA FOR HS CODE 380894
- 5.11.2 EXPORT DATA FOR HS CODE 380894
- 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
- 5.13 REGULATORY LANDSCAPE
- 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.13.2 REGULATORY JURISDICTION
- 5.13.3 REGULATORY ANALYSIS
- 5.13.3.1 North America
- 5.13.3.1.1 US
- 5.13.3.1.2 Canada
- 5.13.3.2 Europe
- 5.13.3.3 Asia Pacific
- 5.13.3.3.1 Japan
- 5.13.3.3.2 India
- 5.13.3.3.3 China
- 5.13.3.4 Latin America
- 5.13.3.4.1 Brazil
- 5.13.3.4.2 Mexico
- 5.13.3.5 Middle East
- 5.13.3.6 Africa
- 5.14 PORTER'S FIVE FORCES ANALYSIS
- 5.14.1 BARGAINING POWER OF BUYERS
- 5.14.2 BARGAINING POWER OF SUPPLIERS
- 5.14.3 THREAT OF NEW ENTRANTS
- 5.14.4 THREAT OF SUBSTITUTES
- 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.15.2 KEY BUYING CRITERIA
- 5.16 IMPACT OF AI/GEN AI ON SURFACE DISINFECTANT MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 MARKET POTENTIAL OF AI IN SURFACE DISINFECTANT MARKET
- 5.16.3 AI USE CASES
- 5.16.4 FUTURE OF GENERATIVE AI IN SURFACE DISINFECTANT ECOSYSTEM
6 SURFACE DISINFECTANT MARKET, BY COMPOSITION
- 6.1 INTRODUCTION
- 6.2 ALCOHOLS
- 6.2.1 INCREASING DEMAND FOR DOMESTIC AND HOSPITAL-GRADE DISINFECTANTS TO SUSTAIN GROWTH
- 6.3 CHLORINE COMPOUNDS
- 6.3.1 MINIMAL ENVIRONMENTAL HAZARDS TO AMPLIFY GROWTH
- 6.4 QUATERNARY AMMONIUM COMPOUNDS
- 6.4.1 ENHANCED RESIDUAL ACTIVITY AND BROAD-SPECTRUM EFFICACY TO STIMULATE GROWTH
- 6.5 HYDROGEN PEROXIDE
- 6.5.1 LOW TOXICITY AND STRONG OXIDIZING PROPERTIES TO SUPPORT GROWTH
- 6.6 PERACETIC ACID
- 6.6.1 WIDE USE AS DISINFECTANT, SANITIZER, BLEACH, STERILANT, INDUSTRIAL REAGENT, OXIDIZER, AND POLYMERIZATION CATALYST TO DRIVE MARKET
- 6.7 PHENOLIC COMPOUNDS
- 6.7.1 RISING FOCUS ON LONG-LASTING INFECTION CONTROL TO FACILITATE GROWTH
- 6.8 OTHER COMPOSITIONS
7 SURFACE DISINFECTANT MARKET, BY TYPE
- 7.1 INTRODUCTION
- 7.2 LIQUIDS
- 7.2.1 COST-EFFECTIVENESS AND HIGH EFFICACY TO ENCOURAGE GROWTH
- 7.3 WIPES
- 7.3.1 ALCOHOL-BASED WIPES
- 7.3.1.1 Stringent infection prevention protocols to contribute to growth
- 7.3.2 QUATERNARY AMMONIUM COMPOUND-BASED WIPES
- 7.3.2.1 Need for efficient, ready-to-use disinfection solutions in medical environment to expedite growth
- 7.3.3 OTHER WIPES
- 7.4 SPRAYS
- 7.4.1 GROWING USE OF SPRAYS IN FOGGING TECHNIQUES TO FUEL MARKET
8 SURFACE DISINFECTANT MARKET, BY APPLICATION
- 8.1 INTRODUCTION
- 8.2 SURFACE DISINFECTION
- 8.2.1 INCREASING PREVALENCE OF HEALTHCARE-ASSOCIATED INFECTIONS TO AUGMENT GROWTH
- 8.3 INSTRUMENT DISINFECTION
- 8.3.1 GROWING USE OF MEDICAL DEVICES IN HOSPITALS AND LABORATORIES TO DRIVE MARKET
- 8.4 OTHER APPLICATIONS
9 SURFACE DISINFECTANT MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 HOSPITALS, CLINICS, AND ASCS
- 9.2.1 GROWING FOCUS ON HOSPITAL HYGIENE TO BOOST MARKET
- 9.3 DIAGNOSTIC LABORATORIES
- 9.3.1 NEED TO ENSURE COMPLIANCE WITH SAFETY AND REGULATORY STANDARDS TO AID GROWTH
- 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 9.4.1 INCREASING FUNDING AND INVESTMENT ACTIVITIES IN PHARMA AND BIOTECH SECTOR TO PROMOTE GROWTH
- 9.5 RESEARCH LABORATORIES
- 9.5.1 GROWING EMPHASIS ON STERILE AND CONTROLLED RESEARCH LABORATORY ENVIRONMENTS TO FUEL MARKET
10 SURFACE DISINFECTANT MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
- 10.2.2.1 Rapid growth in geriatric population to encourage growth
- 10.2.3 CANADA
- 10.2.3.1 High prevalence of healthcare-associated infections to aid growth
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
- 10.3.2.1 High prevalence of HAIs in hospitals and ICUs to support market growth
- 10.3.3 FRANCE
- 10.3.3.1 Favorable insurance and infection control policies to accelerate growth
- 10.3.4 UK
- 10.3.4.1 Increasing funding for clinical trials to amplify growth
- 10.3.5 ITALY
- 10.3.5.1 Increasing geriatric population to favor growth
- 10.3.6 SPAIN
- 10.3.6.1 Growing prevalence of diabetes to drive market
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
- 10.4.2.1 Changing lifestyles and prevalence of obesity to bolster growth
- 10.4.3 JAPAN
- 10.4.3.1 Universal healthcare coverage to contribute to growth
- 10.4.4 INDIA
- 10.4.4.1 Expanding acute care settings to fuel market
- 10.4.5 AUSTRALIA
- 10.4.5.1 Growing rate of chronic diseases to boost market
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Increasing focus on improving healthcare infrastructure to expedite growth
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
- 10.5.2.1 Increased surgical procedures to support growth
- 10.5.3 MEXICO
- 10.5.3.1 Favorable government initiatives to augment growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 RISING HEALTHCARE EXPENDITURE AND ROBUST INFRASTRUCTURE DEVELOPMENT TO EXPEDITE GROWTH
- 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURFACE DISINFECTANT MARKET
- 11.3 REVENUE ANALYSIS, 2019-2023
- 11.4 MARKET SHARE ANALYSIS, 2024
- 11.5 COMPANY VALUATION AND FINANCIAL METRICS
- 11.6 BRAND/PRODUCT COMPARISON
- 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.7.1 STARS
- 11.7.2 EMERGING LEADERS
- 11.7.3 PERVASIVE PLAYERS
- 11.7.4 PARTICIPANTS
- 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.7.5.1 Company footprint
- 11.7.5.2 Region footprint
- 11.7.5.3 Type footprint
- 11.7.5.4 Application footprint
- 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.8.1 PROGRESSIVE COMPANIES
- 11.8.2 RESPONSIVE COMPANIES
- 11.8.3 DYNAMIC COMPANIES
- 11.8.4 STARTING BLOCKS
- 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 11.8.5.1 Detailed list of key startup/SME players
- 11.8.5.2 Competitive benchmarking of key startups/SMEs
- 11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS
- 11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 RECKITT BENCKISER
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Deals
- 12.1.1.3.2 Expansions
- 12.1.1.4 MnM view
- 12.1.1.4.1 Right to win
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 PROCTER & GAMBLE
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 MnM view
- 12.1.2.3.1 Right to win
- 12.1.2.3.2 Strategic choices
- 12.1.2.3.3 Weaknesses and competitive threats
- 12.1.3 3M
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 MnM view
- 12.1.3.3.1 Right to win
- 12.1.3.3.2 Strategic choices
- 12.1.3.3.3 Weaknesses and competitive threats
- 12.1.4 THE CLOROX COMPANY
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 Recent developments
- 12.1.5 ECOLAB
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.6 STERIS
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.7 PAUL HARTMANN AG
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.7.3.1 Product launches
- 12.1.8 SC JOHNSON PROFESSIONAL USA, INC.
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.8.3 Recent developments
- 12.1.8.3.1 Product launches
- 12.1.9 CARROLLCLEAN
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.10 MEDALKAN
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.10.3 Recent developments
- 12.1.10.3.1 Product launches
- 12.1.11 GOJO INDUSTRIES, INC.
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.11.3 Recent developments
- 12.1.11.3.1 Product launches
- 12.1.12 WHITELEY
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.12.3 Recent developments
- 12.1.12.3.1 Other developments
- 12.1.13 SANOSIL AG
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 BETCO
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.15 METREX RESEARCH, LLC
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.2 OTHER PLAYERS
- 12.2.1 ACURO ORGANICS LIMITED
- 12.2.2 PHARMAX LIMITED
- 12.2.3 PDI, INC.
- 12.2.4 RUHOF
- 12.2.5 CARENOW
- 12.2.6 CETYLITE, INC.
- 12.2.7 MICRO-SCIENTIFIC, LLC
- 12.2.8 PAL INTERNATIONAL
- 12.2.9 BRULIN
- 12.2.10 KCWW
- 12.2.11 AMITY INTERNATIONAL
- 12.2.12 WEXFORD LABS, INC.
- 12.2.13 DETROX
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
